A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)
Authors
Keywords
-
Journal
Radiation Oncology
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-12
DOI
10.1186/s13014-020-01593-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
- (2019) Jean-Pascal Machiels et al. Journal for ImmunoTherapy of Cancer
- Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial
- (2018) E Fokas et al. ANNALS OF ONCOLOGY
- Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review
- (2018) Mark T.W. Teo et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical Development of Novel Drug–Radiotherapy Combinations
- (2018) Saif S. Ahmad et al. CLINICAL CANCER RESEARCH
- Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer
- (2017) Emmanouil Fokas et al. JNCI-Journal of the National Cancer Institute
- Tumor Regression Grading After Preoperative Chemoradiotherapy as a Prognostic Factor and Individual-Level Surrogate for Disease-Free Survival in Rectal Cancer
- (2017) Emmanouil Fokas et al. JNCI-Journal of the National Cancer Institute
- Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
- (2017) Arthur Dyer et al. Molecular Therapy-Oncolytics
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
- (2017) Sean M. O’Cathail et al. Frontiers in Oncology
- Combination of Novel Agents with Radiotherapy to Treat Rectal Cancer
- (2016) T.A. Greenhalgh et al. CLINICAL ONCOLOGY
- Clinical development of new drug–radiotherapy combinations
- (2016) Ricky A. Sharma et al. Nature Reviews Clinical Oncology
- Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
- (2015) Claus Rödel et al. LANCET ONCOLOGY
- Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
- (2014) Svend O. Freytag et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
- (2012) T. Y. Seiwert et al. ANNALS OF ONCOLOGY
- EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study
- (2012) J. Randolph Hecht et al. GASTROINTESTINAL ENDOSCOPY
- Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma
- (2011) E. Antonio Chiocca et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer
- (2010) Chunyan Liu et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Serotype-Specific Inactivation of the Cellular DNA Damage Response during Adenovirus Infection
- (2010) N. A. Forrester et al. JOURNAL OF VIROLOGY
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
- Critical aspects of the Bayesian approach to phase I cancer trials
- (2008) Beat Neuenschwander et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started